1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine

Name: 1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine
Brand: MedChemExpress
SKU: HY-141616
Rating: 4.5 (0 reviews)

Cat. No.: HY-141616 Purity: 99.97%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine is an endogenous metabolite present in Blood that can be used for the research of Pregnancy and Sepsis.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine 화학구조

CAS No. : 50930-23-9

사이즈	재고	수량
Solution
10 mM * 1 mL in Methanol	해외재고보유	Estimated Time of Arrival: December 31
Solid
1 mg	해외재고보유	Estimated Time of Arrival: December 31
5 mg	해외재고보유	Estimated Time of Arrival: December 31
10 mg	해외재고보유	Estimated Time of Arrival: December 31
25 mg	해외재고보유	Estimated Time of Arrival: December 31
50 mg	견적 받기
100 mg	견적 받기

or 대량구매 문의

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

This product is a controlled substance and not for sale in your territory.

고객리뷰

Based on 1 Customer Validation

Other Forms of 1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine:

1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine-d₅ 견적 받기

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All Endogenous Metabolite Isoform Specific Products:

View All Isoforms

Human Endogenous Metabolite Microbial Metabolite

Biological Activity
순도&문서
References
고객리뷰

제품 설명

1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine is an endogenous metabolite present in Blood that can be used for the research of Pregnancy and Sepsis^[1]^[2]^[3].

In Vitro

Endogenous metabolites is defined as those that are annotated by Kyoto Encyclopedia of Genes and Genomes as substrates or products of the ~1900 metabolic enzymes encoded in our genome. It is clear in the body of literature that there are documented toxic properties for many of these metabolites^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

분자량

509.66

화학식

C₂₅H₅₂NO₇P

CAS No.

50930-23-9

Appearance

Solid

Color

White to off-white

SMILES

CCCCCCCCCCCCCCCCC(OC[C@@H](O)COP(OCC[N+](C)(C)C)([O-])=O)=O

Structure Classification

Others

Initial Source

Endogenous metabolite

선적

Room temperature in continental US; may vary elsewhere.

보관

Powder	-20°C	3 years
In solvent	-80°C	6 months
	-20°C	1 month

용액&용해도

In Vitro:

Methanol : ≥ 25 mg/mL (49.05 mM)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	1.9621 mL	9.8105 mL	19.6209 mL
5 mM	0.3924 mL	1.9621 mL	3.9242 mL
10 mM	0.1962 mL	0.9810 mL	1.9621 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

몰농도 계산기
농도 희석 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Calculation results:

Working solution concentration: mg/mL

순도&문서

Purity: 99.97%

Select Batch:

Data Sheet (266 KB) SDS (251 KB)

COA (239 KB) HNMR (186 KB) LCMS (91 KB)

Handling Instructions (2659 KB)

References

[1]. Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720. [Content Brief]

[2]. Bahado-Singh RO, et al. Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. [Content Brief]

[3]. Ferrario M, et al. Mortality prediction in patients with severe septic shock: a pilot study using a target metabolomics approach. Sci Rep. 2016 Feb 5;6:20391. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

Methanol	1 mM	1.9621 mL	9.8105 mL	19.6209 mL	49.0523 mL
	5 mM	0.3924 mL	1.9621 mL	3.9242 mL	9.8105 mL
	10 mM	0.1962 mL	0.9810 mL	1.9621 mL	4.9052 mL
	15 mM	0.1308 mL	0.6540 mL	1.3081 mL	3.2702 mL
	20 mM	0.0981 mL	0.4905 mL	0.9810 mL	2.4526 mL
	25 mM	0.0785 mL	0.3924 mL	0.7848 mL	1.9621 mL
	30 mM	0.0654 mL	0.3270 mL	0.6540 mL	1.6351 mL
	40 mM	0.0491 mL	0.2453 mL	0.4905 mL	1.2263 mL